Calidi Biotherapeutics In...

AMEX: CLDI · Real-Time Price · USD
5.28
0.24 (4.76%)
At close: Aug 15, 2025, 3:59 PM
5.24
-0.76%
After-hours: Aug 15, 2025, 07:55 PM EDT

Calidi Biotherapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
9.59M 2.05M 472K 1.06M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
129K 230K 42.45M 230M
Other Long-Term Assets
892K 143K -41.73M -304.06K
Receivables
n/a 1.36M 870.00 n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
249K 125K 302.13K n/a
Total Current Assets
10.23M 4.3M 786K 1.48M
Property-Plant & Equipment
2.93M 5.34M 1.09M 585K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
3.96M 5.72M 1.81M 230.29M
Total Assets
14.18M 10.02M 2.6M 231.77M
Account Payables
2.07M 2.88M 2.27M 624K
Deferred Revenue
n/a n/a n/a -5.14M
Short-Term Debt
3.18M 807K 5.42M 5M
Other Current Liabilities
2K n/a 29.83M 21.83M
Total Current Liabilities
9.5M 10.23M 42.99M 25.96M
Long-Term Debt
600K 2.06M n/a n/a
Other Long-Term Liabilities
128K 2.71M 624.23K 16M
Total Long-Term Liabilities
2.72M 8.02M 447K 16.04M
Total Liabilities
12.21M 18.25M 43.44M 16.45M
Total Debt
7.04M 7.24M 5.99M 5.18M
Common Stock
2K 4K 2K 2K
Retained Earnings
-121.72M -99.57M -70.36M -44.93M
Comprehensive Income
-28K -47K -14K -1K
Shareholders Equity
1.53M -8.23M -40.84M -22.61M
Total Investments
129K 230K 42.45M 230M